Back to search

Article

Harnessing subtractive genomics for drug target identification in <i>Streptococcus agalactiae</i> serotype v (atcc baa-611 / 2603 v/r) strain: An <i>in-silico</i> approach

2025-02-08

Abstract excerpt

Developing a therapeutic target for bacterial disease is challenging. In silico subtractive genomics methodology offer a promising alternative to traditional drug discovery methods. Streptococcus agalactiae infections depend on two crucial criteria: drug-resistance and the existence of virulence factors. It is essential to underline that S. agalactiae strains have emerged to be resistant to several drugs. Hence...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
dcf66389-4c16-5669-98a0-b5202348fbb3
DOI
10.1101/2025.02.04.636418
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Harnessing subtractive genomics for drug target identification in <i>Streptococcus agalactiae</i> serotype v (atcc baa-611 / 2603 v/r) strain: An <i>in-silico</i> approachDOI 10.1101/2025.02.04.636418
Subtractive Genome Analysis for Identification and Characterization of Novel Drug Targets in the Streptococcus pneumoniae by Using In-silico ApproachSemantic proximity
Genome-Based Drug Target Identification in Human Pathogen Streptococcus gallolyticusSemantic proximity
Subtractive genomics and drug repurposing strategies for targeting Streptococcus pneumoniae: insights from molecular docking and dynamics simulationsSemantic proximity
Analysis of Structure and Function of Putative Surface-Exposed Proteins Encoded in the<i>Streptococcus pneumoniae</i>Genome: A Bioinformatics-Based Approach to Vaccine and Drug DesignSemantic proximity
Subtractive genomics profiling for potential drug targets identification against Moraxella catarrhalisSemantic proximity
In Silico Subtractive Proteomics and Molecular Docking Approaches for the Identification of Novel Inhibitors against Streptococcus pneumoniae Strain D39Semantic proximity
Subtractive genome analysis for in silico identification and characterization of novel drug targets in Streptococcus pneumonia strain JJASemantic proximity
The Role and Regulatory Network of the CiaRH Two-Component System in Streptococcal SpeciesSemantic proximity
Core proteome subtractive genomics reveals potential therapeutic targets in Bacillus anthracisSemantic proximity
<i>In Silico</i> identification of potential drug targets by subtractive genome analysis of <i>Enterococcus faecium DO</i>Semantic proximity
Complete genome sequence and comparative genomic analysis of an emerging human pathogen, serotype V <i>Streptococcus agalactiae</i>Semantic proximity
Subtractive Genomics Approach for in Silico Identification and Characterization of Novel Drug Targets in Neisseria Meningitides Serogroup BSemantic proximity
Select a neighboring publication to make it the new centre.